BCTX

BRIACELL THERAPEUTICS CORP

BCTX·107930307·US·Common Stock·Healthcare - Biotechnology-13D/G

BCTX (BRIACELL THERAPEUTICS CORP) is held by 11 institutional investors as of Q2 2026. Largest holders: UBS Group AG ($141,400), JANE STREET GROUP, LLC ($85,909), NATIONAL BANK OF CANADA /FI/ ($5,796). Net institutional sentiment: Bullish.

11
Holders
(1 Elite)
$239,454
Total Value
71% (7)
Consensus
5 buying - 2 selling
13F: Insider & Congress: Updated regularly
BCTX

Smart Money Verdict

View all
Loading verdict
Held by 11 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Jan 23, 2026 · Congress none

ActivistCitadel Advisors LLCCitadel Advisors LLC10.0%Jan 23, 2026
ActivistIRIroquois Capital Management, LLC3.0%Nov 14, 2025
ActivistCICVI Investments, Inc.4.9%Nov 7, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
43,642(+278.1%)$141,4000.0%+13.67%
24
New
26,515$85,9090.0%+24.38%
33
Increased
1,803(+124.8%)$5,7960.0%+12.35%
17
Decreased
1,033(-65.8%)$3,3470.0%-48.35%
0
Decreased
450(-1.1%)$1,4440.0%-83.29%
0
Increased
289(+189.0%)$1,0000.0%-71.21%
12
Unchanged
100$3240.0%-55.86%
0
New
34,904$1130.0%+24.38%
15
Unchanged
19$660.0%-89.85%
0
Unchanged
16$520.0%-89.85%
0
Unchanged
1$30.0%-89.85%
0
BCTXBCTXBRIACELL THERAPEUTICS CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used